Skip to content

Evaluation of Metal-on-conventional-polyethylene vs Ceramic-on-ceramic Articulating Surfaces in Total Hip Arthroplasty

Randomized Evaluation of Metal-on-conventional-polyethylene vs Ceramic-on-ceramic Articulating Surfaces in Uncemented Total Hip Arthroplasty: A Radiostereometry Study Including 104 Patients

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03692364
Enrollment
104
Registered
2018-10-02
Start date
2003-10-02
Completion date
2022-12-31
Last updated
2018-10-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Arthroplasty Complications

Keywords

biomaterials, Implant wear, hip arthroplasty, osteolysis, aseptic loosening

Brief summary

Polyethylene wear debris from metal-on-polyethylene articulations are one of the main causes of periprosthetic bone loss and non-infectious loosening in total hip arthroplasty. Ceramic articulations have a very low wear rate when measured in the laboratory and the investigator's hypothesis is that hip arthroplasty with an all ceramic articulation will have less osteolysis and wear in addition to equally good fixation and clinical outcome compared to the same hip arthroplasty design with a metal-on-polyethylene joint.

Interventions

DEVICECeramic-on-ceramic uncemented hip arthroplasty
DEVICEMetal-on-polyethylene uncemented total hip arthroplasty

Sponsors

Stryker Nordic
CollaboratorINDUSTRY
Sahlgrenska University Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Intervention model description

Prospective randomized study

Eligibility

Sex/Gender
ALL
Age
35 Years to 64 Years
Healthy volunteers
No

Inclusion criteria

* primary osteoarthritis * secondary osteoarthritis caused by idiopathic osteonecrosis, dysplasia or childhood disease (Mb Perthes, epiphysiolysis)

Exclusion criteria

* inflammatory arthritis * hip joint infection

Design outcomes

Primary

MeasureTime frameDescription
Osteolysis size change between 7 and 15 yearsChange between 7 and 15 years after surgeryOsteolysis size (cm3) measured with computed tomography
Osteolysis frequency change between 7 and 15 yearsChange between 7 to 15 years after surgeryOsteolysis frequency (%) measured with computed tomography,

Secondary

MeasureTime frameDescription
Implant fixation at 7 years7 years after surgeryStem and cup translation (mm/year) and rotation (degrees/year) measured with radiostereometry
Implant fixation at 15 yearsAt 15 years after surgeryStem and cup translation (mm/year) and rotation (degrees/year) measured with radiostereometry
Articulation wear at 7 yearsAt 7 years after surgeryArticulation wear as measured with radiostereometry, mm/year
Clinical function at 15 years15 years after surgeryHarris Hip Score (0-100)
Clinical function at 7 years7 years after surgeryHarris Hip Score (0-100)
Articulation wear at 15 years15 years after surgeryArticulation wear as measured with radiostereometry, mm/year

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026